Archives of Cancer Biology and Therapy

Research Article Open Access

Uniportal VATS Lobectomy for Lung Cancer: Feasibility and Cost Effectiveness in a Single Center Experience

Crucitti Pierfilippo, Longo Filippo, Tacchi Giovanni, Manca Paolo, Frasca Luca, Carannante Filippo, Spoto Silvia, Citarella Fabrizio, Tonini Giuseppe

In last decades, video-assisted thoracic surgery (VATS) together with robotic-assisted thoracic surgery (RATS) can be considered the biggest innovation in thoracic surgery. This approach drastically changed the way of performing surgical operations, improving patient’s outcome undergoing thoracic surgery.

Editorial Open Access

Angioimmunoblastic T cell Lymphoma Microenvironment

Sergiu Pasca, Ancuta Jurj, Daniela Matei

Angioimmunoblastic T cell lymphoma (AITL) is one of the most common T-cell lymphomas, second only to peripheral T-cell lymphoma not otherwise specified (PTCL-NOS). Initially AITL was considered a non-malignant lymphadenopathy with immune hyperactivation, nowadays being classified as a PTCL.

Mini Review Open Access

Searching for Easy Reliable Prognostic Parametres in Colorectal Cancer Patients Evaluation

Eva Lieto, Annamaria Auricchio, Nicoletta Basile, Silvia Erario, Giovanni Del Sorbo, Marco D’Ambrosio, Paolo Castellano, Francesca Cardella

Despite the advances in diagnostic and therapeutic field, colorectal cancer (CRC) still remains the third most common cause of death worldwide, with more than 600,000 cancer-related deaths per year.

Short Communication Open Access

Impact of Cisplatin Dosing Regimens on Mammary Tumor Growth in an Animal Model

James A. Koziol, Theresa J. Falls, Jan E. Schnitzer

In a recent paper, we introduced a variant of the classical Simeoni tumor growth model, and illustrated its value in assessing tumor growth in a reproducible mouse model for mammary tumors. Our modification consisted of incorporating delay differential equations in the mathematical formulation of the Simeoni model, to represent the delay in drug action often observed under chemotherapeutic or immunotherapeutic regimens.

Editorial Open Access

Lessons Learnt from COVID-19: How Can We Prepare for Another Pandemic?

Matthew I. Ehrlich, Muhammad Wasif Saif

Five months into the COVID-19 pandemic, the U.S. death toll from the virus has now surpassed 100,000 people. Many more cases remain nationwide, while an unknown number of patients currently harbor the virus asymptomatically. While health officials are now optimistic regarding the decline in prevalence and number of deaths due to COVID-19 and the possibility of a vaccine by the fall, we cannot lose sight of the bigger picture: the next pandemic.